Biomea Fusion Inc (BMEA)
12.22
-0.56
(-4.38%)
USD |
NASDAQ |
May 17, 16:00
12.22
0.00 (0.00%)
Pre-Market: 20:00
Biomea Fusion Shareholders Equity (Quarterly): 135.31M for March 31, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 135.31M |
| December 31, 2023 | 169.24M |
| September 30, 2023 | 199.61M |
| June 30, 2023 | 224.30M |
| March 31, 2023 | 83.13M |
| December 31, 2022 | 108.54M |
| September 30, 2022 | 130.64M |
| Date | Value |
|---|---|
| June 30, 2022 | 150.39M |
| March 31, 2022 | 164.76M |
| December 31, 2021 | 178.78M |
| September 30, 2021 | 191.33M |
| June 30, 2021 | 202.02M |
| March 31, 2021 | 0.221M |
| December 31, 2020 | 5.169M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
0.221M
Minimum
Mar 2021
224.30M
Maximum
Jun 2023
138.82M
Average
157.58M
Median
Shareholders Equity (Quarterly) Benchmarks
| Poseida Therapeutics Inc | 84.59M |
| Cartesian Therapeutics Inc | -116.80M |
| BioXcel Therapeutics Inc | -72.36M |
| NovaBay Pharmaceuticals Inc | 0.16M |
| Palatin Technologies Inc | 1.579M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 168.49M |
| Total Liabilities (Quarterly) | 33.18M |